This working paper aims to synthesise existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system.

This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks. 

While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...

The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...

In this note, we review Colombia's handling of the COVID-19 crisis. The first line of policy response slowed down the pace of contagion and avoided excess deaths, providing additional time to strengthen the health system and increase ICU capacity. However, the challenges that remain are significant....

This paper assesses Colombia’s recent expansion in comprehensive early childhood care, underscoring the importance of strong high-level political commitment, inter-institutional coordination and stable financing.